269 related articles for article (PubMed ID: 7799031)
1. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Motzer RJ; Rodriguez E; Reuter VE; Bosl GJ; Mazumdar M; Chaganti RS
J Clin Oncol; 1995 Jan; 13(1):274-82. PubMed ID: 7799031
[TBL] [Abstract][Full Text] [Related]
2. Poorly differentiated carcinoma and germ cell tumors.
Hainsworth JD; Greco FA
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1223-31. PubMed ID: 1663941
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.
Motzer RJ; Rodriguez E; Reuter VE; Samaniego F; Dmitrovsky E; Bajorin DF; Pfister DG; Parsa NZ; Chaganti RS; Bosl GJ
J Natl Cancer Inst; 1991 Mar; 83(5):341-6. PubMed ID: 1847433
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the i(12p) marker chromosome in germ cell tumors.
Bosl GJ; Ilson DH; Rodriguez E; Motzer RJ; Reuter VE; Chaganti RS
J Natl Cancer Inst; 1994 Mar; 86(5):349-55. PubMed ID: 8308927
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site.
Ilson DH; Motzer RJ; Rodriguez E; Chaganti RS; Bosl GJ
Semin Oncol; 1993 Jun; 20(3):229-37. PubMed ID: 8503018
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization.
Schneider DT; Schuster AE; Fritsch MK; Calaminus G; Harms D; Göbel U; Perlman EJ
Klin Padiatr; 2001; 213(4):204-11. PubMed ID: 11528555
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors.
Rodriguez E; Houldsworth J; Reuter VE; Meltzer P; Zhang J; Trent JM; Bosl GJ; Chaganti RS
Genes Chromosomes Cancer; 1993 Dec; 8(4):230-6. PubMed ID: 7512366
[TBL] [Abstract][Full Text] [Related]
8. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.
Motzer RJ; Amsterdam A; Prieto V; Sheinfeld J; Murty VV; Mazumdar M; Bosl GJ; Chaganti RS; Reuter VE
J Urol; 1998 Jan; 159(1):133-8. PubMed ID: 9400455
[TBL] [Abstract][Full Text] [Related]
9. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization.
Suijkerbuijk RF; Sinke RJ; Meloni AM; Parrington JM; van Echten J; de Jong B; Oosterhuis JW; Sandberg AA; Geurts van Kessel A
Cancer Genet Cytogenet; 1993 Oct; 70(2):85-93. PubMed ID: 8242603
[TBL] [Abstract][Full Text] [Related]
10. Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
Greco FA; Johnson DH; Hainsworth JD
Semin Oncol; 1992 Dec; 19(6 Suppl 13):14-8. PubMed ID: 1492223
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Christodoulou J; Schoch C; Schnittger S; Haferlach T
Ann Hematol; 2004 Jun; 83(6):386-9. PubMed ID: 14615911
[TBL] [Abstract][Full Text] [Related]
12. Definition of chromosome aberrations in testicular germ cell tumor cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses.
Summersgill BM; Jafer O; Wang R; Goker H; Niculescu-Duvaz I; Huddart R; Shipley J
Cancer Genet Cytogenet; 2001 Jul; 128(2):120-9. PubMed ID: 11463450
[TBL] [Abstract][Full Text] [Related]
13. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases.
Sung MT; Maclennan GT; Lopez-Beltran A; Zhang S; Montironi R; Cheng L
Am J Surg Pathol; 2008 Jan; 32(1):146-55. PubMed ID: 18162782
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors.
Kernek KM; Brunelli M; Ulbright TM; Eble JN; Martignoni G; Zhang S; Michael H; Cummings OW; Cheng L
Mod Pathol; 2004 Nov; 17(11):1309-13. PubMed ID: 15167939
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
Hainsworth JD; Johnson DH; Greco FA
J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
[TBL] [Abstract][Full Text] [Related]
16. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors.
Bosl GJ; Dmitrovsky E; Reuter VE; Samaniego F; Rodriguez E; Geller NL; Chaganti RS
J Natl Cancer Inst; 1989 Dec; 81(24):1874-8. PubMed ID: 2556586
[TBL] [Abstract][Full Text] [Related]
17. [Cytogenetic aspects of pediatric germ cell tumors].
Stock C; Ambros IM; Strehl S; Zoubek A; Fink FM; Gadner H; Ambros PF
Klin Padiatr; 1995; 207(4):235-41. PubMed ID: 7564160
[TBL] [Abstract][Full Text] [Related]
18. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
Greco FA; Hainsworth JD
Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
Hainsworth JD; Erland JB; Kalman LA; Schreeder MT; Greco FA
J Clin Oncol; 1997 Jun; 15(6):2385-93. PubMed ID: 9196154
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
